Zhang Ao, Zhou Guochun, Rong Suo-Bao, Johnson Kenneth M, Zhang Mei, Kozikowski Alan P
Drug Discovery Program, Department of Neurology, Georgetown University Medical Center, 3900 Reservoir Road, NW, Washington, DC 20007-2197, USA.
Bioorg Med Chem Lett. 2002 Apr 8;12(7):993-5. doi: 10.1016/s0960-894x(02)00103-8.
A series of (1S,3S,6R,10S)-(Z)-9-(thienylmethylene- or substituted thienylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes was prepared and evaluated for the ability to block dopamine, serotonin, and norepinephrine reuptake by their respective transporters. Compound 5b is a NET-selective inhibitor, 5c is a mixed NET- and SERT-selective inhibitor, while 11 is a SERT-selective inhibitor.
制备了一系列(1S,3S,6R,10S)-(Z)-9-(噻吩基亚甲基或取代噻吩基亚甲基)-7-氮杂三环[4.3.1.0(3,7)]癸烷,并评估了它们通过各自转运体阻断多巴胺、5-羟色胺和去甲肾上腺素再摄取的能力。化合物5b是一种去甲肾上腺素转运体(NET)选择性抑制剂,5c是一种NET和5-羟色胺转运体(SERT)混合选择性抑制剂,而11是一种SERT选择性抑制剂。